# Arbutus Biopharma Corp: Form 8-K, filed Aug 3, 2017

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2017-08-03
- Accepted by EDGAR: Aug 3, 2017, 16:00 ET
- Period: 2017-08-03
- Accession: 0001171843-17-004691
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184317004691/f8k_080317.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184317004691/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184317004691/f8k_080317.htm

Filed Aug 3, 2017.
Source: SEC EDGAR, the filing index for accession 0001171843-17-004691. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
